Healthcare: Clinical trial inefficiencies and the role of artificial intelligence
On the Bid is a new Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Oriel Morrison discusses the healthcare apps market.
Populating the expert panel this week is Michelle Gallaher, CEO of Opyl (ASX:OPL).
The group discusses a range of topics, including shortcomings in the global clinical trial market, Opyl’s origins and core focus, the company’s launch of Opin, COVID-19 vaccine predictions, AI applications in healthcare sector and more.
So click above to tune in!
Related Topics

UNLOCK INSIGHTS
Discover the untold stories of emerging ASX stocks.
Daily news and expert analysis, it's free to subscribe.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.